Grandomics
GrandOmics, Oxford Nanopore Partner on 100K Human Genomes Structural Variation Project
The project plans to sequence 20,000 genomes in 2019, 50,000 by the end of 2020, and a total of 100,000 by the end of 2021 using Oxford Nanopore's PromethIon platform.
Grandomics Raises Nearly RMB 100M in Series B Financing
The Beijing-based firm said it will use the funding for research and development, to obtain additional intellectual property, and to pursue its strategic goals.
Oxford Nanopore Names Chinese Distributor, Plans to Open New Shanghai Office
The company said that several companies in China are installing the GridIon X5 sequencing platform for in-house and service work.